Indegene Limited is excited to announce that its wholly-owned subsidiary, Indegene Ireland Limited, has signed a Share Purchase Agreement to acquire 100% of the shares of Warn and Co Limited, a UK-based business consulting firm, on October 16, 2025.
About the Acquisition:
Warn and Co Limited, established in 2013, specializes in business transformation consulting, offering services such as change management, organizational design, and solution design to clients, including life sciences companies. The company reported an unaudited revenue of GBP 2.5 million in the last financial year (May 2024 – April 2025).
This acquisition is aimed at strengthening Indegene’s consulting capabilities in the life sciences sector, allowing the company to deliver even more comprehensive solutions to its clients. The deal is an all-cash transaction, with a total consideration not exceeding GBP 3 million, including deferred performance-based payments, and is expected to be completed by October 17, 2025.
Indegene confirms that this acquisition is not a related-party transaction, and no promoter or promoter group interests are involved. No governmental or regulatory approvals are required for this transaction.
